Stay updated with breaking news from Concomitant Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant...
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant medication in pediatric patients with...
STOUGHTON, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutic...
THE WOODLANDS, Texas, Aug. 21, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that analyses of clinical study results relating to INPEFA™ , its recently approved drug for heart...
THE WOODLANDS, Texas, July 28, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that Diane E. Sullivan has been elected to its Board of Directors. Ms. Sullivan brings extensive...